NCT04889547

Brief Summary

The study is designed to assess the use of intraoperative dexamethasone on postoperative analgesia and stiffness after open reduction and internal fixation of distal radius fractures. The idea is that the dexamethasone will aid in reducing postoperative swelling which will then improve pain control as well as overall function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jul 2021

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 17, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

July 10, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

2 years

First QC Date

April 5, 2021

Last Update Submit

October 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient rated wrist evaluation

    15-item questionnaire designed to measure wrist pain and disability in activities of daily living. PWRE will be assessed at multiple time point to assess for change in the score. The higher the score, the more function exhibited.

    48 hours, 1 week, 2 weeks

Secondary Outcomes (3)

  • Finger-to-palm distance

    48 hours, 1 week, 2 weeks

  • Visual analog scale

    48 hours, 1 week, 2 weeks

  • Total opioid consumption

    48 hours, 1 week, 2 weeks

Study Arms (2)

Dexamethasone

EXPERIMENTAL

Patient will receive intraoperative dexamethasone during distal radius open reduction and internal fixation

Drug: Dexamethasone

No dexamethasone

PLACEBO COMPARATOR

Patient will not receive intraoperative dexamethasone during distal radius open reduction and internal fixation

Other: No dexamethasone

Interventions

Intraoperative intravenous dexamethasone

Dexamethasone

No intraoperative intravenous dexamethasone

No dexamethasone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of signed and dated informed consent form
  • Willingness to comply with study procedures and
  • Male or female greater than 18 years old
  • American Society of Anesthesia class I/II/III
  • Ability to take oral medicine in order to assess opioid regimen postop
  • Distal radius open reduction and internal fixation surgery with single incision and volar plate
  • Ability to consent for and receive a preoperative upper extremity nerve block by anesthesia

You may not qualify if:

  • Chronic opioid users
  • Prescriptions for selective-serotonin reuptake inhibitors, gabapentin, duloxetine within 3 days of surgery
  • History of diabetes and A1C \> 8
  • Systemic glucocorticoids within 1 month of study enrollment
  • Inability to take ibuprofen or acetaminophen due to allergy or condition
  • History of hepatitis
  • Pregnancy or lactation
  • Allergic to opioids
  • Known allergic reactions to components of IV dexamethasone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Shore University Hospital

Manhasset, New York, 11030, United States

Location

MeSH Terms

Conditions

Wrist Fractures

Interventions

Dexamethasone

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2021

First Posted

May 17, 2021

Study Start

July 10, 2021

Primary Completion

July 1, 2023

Study Completion

September 1, 2023

Last Updated

October 23, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Locations